The emergence of multidrug-resistant Klebsiella pneumoniae has rendered a large array of
infections difficult to treat. In a high-throughput genetic screen of factors required for K. pneumoniae survival in the lung,
amino acid biosynthesis genes were critical for
infection in both immunosuppressed and wild-type (WT) mice. The limited pool of
amino acids in the lung did not change during
infection and was insufficient for K. pneumoniae to overcome attenuating mutations in aroA, hisA, leuA, leuB, serA, serB, trpE, and tyrA in WT and immunosuppressed mice. Deletion of aroA, which encodes 5-enolpyruvylshikimate-3-phosphate (
EPSP) synthase class I, resulted in the most severe attenuation. Treatment with the
EPSP synthase-specific competitive inhibitor
glyphosate decreased K. pneumoniae growth in the lungs. K. pneumoniae expressing two previously identified
glyphosate-resistant mutations in
EPSP synthase had significant colonization defects in lung
infection. Selection and characterization of six spontaneously
glyphosate-resistant mutants in K. pneumoniae yielded no mutations in aroA Strikingly,
glyphosate treatment of mice lowered the bacterial burden of two of three spontaneous
glyphosate-resistant mutants and further lowered the burden of the less-attenuated
EPSP synthase catalytic mutant. Of 39 clinical isolate strains, 9 were resistant to
glyphosate at levels comparable to those of selected resistant strains, and none appeared to be more highly resistant. These findings demonstrate
amino acid biosynthetic pathways essential for K. pneumoniae
infection are promising novel therapeutic targets.